posted on 2012-10-24, 09:02authored byTimothy J. Coats, Beverly Hunt, Ian Roberts, Haleema Shakur
This article is an invitation to doctors around the world to participate in the CRASH-2 trial (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage), a large, multi-centre, randomised controlled trial of a simple and widely practicable treatment for traumatic hemorrhage. The rationale for the trial and contact details for those who would like to take part are given below. [Introduction]